|
|
 |
|
Argus Safety™ 4.2 is proven to be robust in large and small pharma environments.
Irvine, Calif. – June 4, 2008 – Relsys International, the leading provider of drug safety, pharmacovigilance and risk management solutions for the pharmaceutical industry, announced that, in recent weeks, numerous existing and new Argus clients have successfully been deployed and gone live with the Argus 4.2 platform. This includes a global Top 10 pharmaceutical company, proving that the platform is robust and scalable in large and global environments. Currently, almost 70% of Argus clients are either in production or in the implementation phase of the Argus 4.2 release, with several more companies expected to go live shortly.
John Loucks, Relsys’ Chief Customer Officer, commented: “We are pleased that Argus 4.2 has been shown to be robust in a Top 10 pharma environment, much as it has in smaller company environments. This validates that the latest platform has been attractive to both existing clients as well as new clients and we remain committed to offering the most advanced product in the market.”
Parties interested in learning more about the Argus Safety™ 4.2 Suite, including the most advanced risk management capabilities in the industry, may visit the Relsys exhibit at the upcoming DIA Annual Meeting in June 2008 in Boston, MA or can contact us at info@relsys.net.
About Relsys International
Relsys International provides the industry-leading Argus suite, a complete systems solution for Drug Safety, Pharmacovigilance and Risk Management that helps pharmaceutical, biotech and medical device companies improve drug safety and ensure ongoing compliance with global regulations. The company, founded in 1987, works in partnership with its customers to develop and deliver innovative solutions to long-term business needs, and to provide critical components to support its clients’ corporate risk management strategies. Argus Safety™, the company’s flagship product, is the world’s best selling drug safety and adverse event reporting software, and is used by more of the leading pharmaceutical companies than any other solution. Relsys is a privately held company, headquartered in Irvine, California. For more information, visit www.relsys.net, or call +1 949-453-1715.
Back to News Headlines
|
|
